Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (311-320 of 364) with videos related to

Pageof 37
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 21, 2025
Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade KFreja Cm Kirsebom, Catherine Thompson, Tiina Talts, et al.
The Journal of Infection|April 11, 2022
Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel networkHeather Whitaker, Ruby S M Tsang, Elizabeth Button, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2025
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Mc Rose, Héloïse Lucaccioni, Kimberly Marsh, et al.
Vaccine|November 6, 2019
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard G Pebody, Heather Whitaker, Joanna Ellis, et al.
Nature Communications|February 16, 2023
Optimal age targeting for pneumococcal vaccination in older adults; a modelling studyDeus Thindwa, Samuel Clifford, Jackie Kleynhans, et al.
The Lancet. Global Health|December 20, 2024
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in UgandaEve Nakabembe, Melanie Greenland, Kyle Amaral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
Microbiology Spectrum|January 5, 2022
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG MeasurementsKatja Hoschler, Samreen Ijaz, Nick Andrews, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2019
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18Richard Pebody, Abdelmajid Djennad, Joanna Ellis, et al.
Research and Practice in Thrombosis and Haemostasis|April 27, 2022
Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in EnglandHannah Higgins, Nick Andrews, Julia Stowe, et al.
Pageof 37

Showing results (311-320 of 364) with videos related to

Sort By:
Pageof 37
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 21, 2025
Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade KFreja Cm Kirsebom, Catherine Thompson, Tiina Talts, et al.
The Journal of Infection|April 11, 2022
Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel networkHeather Whitaker, Ruby S M Tsang, Elizabeth Button, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2025
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Mc Rose, Héloïse Lucaccioni, Kimberly Marsh, et al.
Vaccine|November 6, 2019
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard G Pebody, Heather Whitaker, Joanna Ellis, et al.
Nature Communications|February 16, 2023
Optimal age targeting for pneumococcal vaccination in older adults; a modelling studyDeus Thindwa, Samuel Clifford, Jackie Kleynhans, et al.
The Lancet. Global Health|December 20, 2024
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in UgandaEve Nakabembe, Melanie Greenland, Kyle Amaral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
Microbiology Spectrum|January 5, 2022
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG MeasurementsKatja Hoschler, Samreen Ijaz, Nick Andrews, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2019
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18Richard Pebody, Abdelmajid Djennad, Joanna Ellis, et al.
Research and Practice in Thrombosis and Haemostasis|April 27, 2022
Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in EnglandHannah Higgins, Nick Andrews, Julia Stowe, et al.
Pageof 37